Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Tissue Cell ; 80: 101990, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36542947

ABSTRACT

Colorectal cancer is the second leading cause of cancer and often has a fatal course. There are many studies in the literature that have described a close functional relationship between the tumor mass and surrounding tissue, or tumor stroma, which is affected by the continuous metabolic exchange that occurs at the interface between tumor and tissues in contact with it. There is much evidence that the presence of adipose tissue in stroma plays a fundamental role in modulating the tumor microenvironment and promote tumor development, growth, and angiogenesis due to its endocrine characteristics. In this analysis, we have studied the alterations of adipose tissue surrounding colorectal tumors with MRI and optical imaging in vivo techniques to monitor tumor progression and also performed histological and molecular analysis. We detected differences in the principal adipose markers expressed by adipocytes residing around the rectal colon and observed that peritumoral adipose tissue is exposed to a mesenchymal transition process that leads to the acquisition of a less differentiated phenotype of adipocyte that represents the main cellular type present in tumor stroma. The mesenchymal transition correlated with the acquisition of more aggressive tumor phenotype and could represent a valid target for tumor therapy.


Subject(s)
Carcinoma , Colonic Neoplasms , Humans , Adipose Tissue/metabolism , Adipocytes/metabolism , Colonic Neoplasms/pathology , Carcinoma/metabolism , Carcinoma/pathology , Tumor Microenvironment
2.
Clin Exp Immunol ; 203(1): 87-95, 2021 01.
Article in English | MEDLINE | ID: mdl-32946591

ABSTRACT

Pseudomonas aeruginosa is the major respiratory pathogen in patients with cystic fibrosis (CF). P. aeruginosa-secreted proteases, in addition to host proteases, degrade lung tissue and interfere with immune processes. In this study, we aimed at evaluating the possible anti-inflammatory effects of protease inhibitors Marimastat and Ilomastat in the treatment of P. aeruginosa infection. Lung infection with the P. aeruginosa PAO1 strain was established in wild-type and cystic fibrosis transmembrane conductance regulator (CFTR) knock-out C57BL/6 mice expressing a luciferase gene under control of bovine interleukin (IL)-8 promoter. After intratracheal instillation with 150 µM Marimastat and Ilomastat, lung inflammation was monitored by in-vivo bioluminescence imaging and bacterial load in the lungs was assessed. In vitro, the effects of protease inhibitors on PAO1 growth and viability were evaluated. Acute lung infection was established in both wild-type and CFTR knock-out mice. After 24 h, the infection induced IL-8-dependent bioluminescence emission, indicating lung inflammation. In infected mice with ongoing inflammation, intratracheal treatment with 150 µM Marimastat and Ilomastat reduced the bioluminescence signal in comparison to untreated, infected animals. Bacterial load in the lungs was not affected by the treatment, and in vitro the same dose of Marimastat and Ilomastat did not affect PAO1 growth and viability, confirming that these molecules have no additional anti-bacterial activity. Our results show that inhibition of protease activity elicits anti-inflammatory effects in cystic fibrosis (CF) mice with acute P. aeruginosa lung infection. Thus, Marimastat and Ilomastat represent candidate molecules for the treatment of CF patients, encouraging further studies on protease inhibitors and their application in inflammatory diseases.


Subject(s)
Cystic Fibrosis/drug therapy , Hydroxamic Acids/pharmacology , Indoles/pharmacology , Pneumonia, Bacterial/drug therapy , Protease Inhibitors/pharmacology , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/immunology , Acute Disease , Animals , Cystic Fibrosis/genetics , Cystic Fibrosis/immunology , Cystic Fibrosis/pathology , Mice , Mice, Knockout , Pneumonia, Bacterial/genetics , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/pathology , Pseudomonas Infections/genetics , Pseudomonas Infections/immunology , Pseudomonas Infections/pathology
3.
Int J Pharm ; 560: 347-356, 2019 Apr 05.
Article in English | MEDLINE | ID: mdl-30797075

ABSTRACT

The use of nanoparticles as drug carriers in the field of skeletal muscle diseases has been poorly addressed and the interaction of nanoparticles with skeletal muscle cells has been investigated almost exclusively on C2C12 murine myoblasts. In this study we investigated the effects poly(lactide-co-glycolide) nanoparticles, mesoporous silica nanoparticles and liposomes, on the viability of primary human myoblasts and analyzed their cellular uptake and intracellular distribution in both primary human myoblasts and myotubes. Our data demonstrate that poly(lactide-co-glycolide) nanoparticles do not negatively affect myoblasts viability, contrarily to mesoporous silica nanoparticles and liposomes that induce a decrease in cell viability at the highest doses and longest incubation time. Poly(lactide-co-glycolide) nanoparticles and mesoporous silica nanoparticles are internalized by endocytosis, poly(lactide-co-glycolide) nanoparticles undergo endosomal escape whereas mesoporous silica nanoparticles always occur within vacuoles. Liposomes were rarely observed within the cells. The uptake of all tested nanoparticles was less prominent in primary human myotubes as compared to myoblasts. Our findings represent the first step toward the characterization of the interaction between nanoparticles and primary human muscle cells and suggest that poly(lactide-co-glycolide) nanoparticles might find an application for drug delivery to skeletal muscle.


Subject(s)
Muscle Fibers, Skeletal/metabolism , Myoblasts/metabolism , Nanoparticles , Silicon Dioxide/chemistry , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Delivery Systems , Endocytosis , Humans , Liposomes , Polyglactin 910/chemistry , Porosity , Time Factors
4.
J Neural Transm (Vienna) ; 124(3): 347-352, 2017 03.
Article in English | MEDLINE | ID: mdl-27812756

ABSTRACT

It is well known that Parkinson's disease is characterized by a variety of non-motor symptoms. A gustatory deficit is hypothesized to be one of them although few and only cross-sectional studies are available. The aim of our pilot study was to prospectively investigate the taste function in Parkinson's disease patients after some years from the first evaluation (mean follow-up 4.35 ± 0.49 years; time range 3.5-5.6 years). A group of 26 patients was re-examined (16 males and 10 females; mean age 70.9 ± 8.4 years, range 54-88 years). Taste function was assessed in one session, by means of the Whole Mouth Test (WMT) and Taste Strips Test (TST). Olfaction was also evaluated with the Sniffin' Sticks Identification Test (SST). All these tests are commercially available (Burghart Company, Germany). All patients were able to understand and complete the procedure. Although scores decreased over time, no significant difference was found between global taste scores of first and second evaluation, neither comparing every single taste quality (WMT: p = 0.234, Mann-Whitney U test; TST: p = 0.747, Mann-Whitney U test; McNemar chi-square in the range of 0-1.455). These results confirm a persistent but slight and stable taste impairment, in patients with Parkinson's disease. Future studies on a much larger sample of patients are certainly required.


Subject(s)
Parkinson Disease/physiopathology , Taste , Aged , Aged, 80 and over , Disease Progression , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pilot Projects , Prospective Studies
5.
Eur J Histochem ; 60(1): 2557, 2016 Feb 01.
Article in English | MEDLINE | ID: mdl-26972710

ABSTRACT

Recent studies indicate that the processes mediated by the (T1R2/T1R3) glucose/sugar receptor of gustatory cells in the tongue, and hormones like leptin and ghrelin contribute to the regulation of glucose homeostasis. Altered plasma levels of leptin and ghrelin are associated with obesity both in humans and rodents. In the present study, we evaluated the ultrastructure of the mucosa, and the expression of molecules implicated in the regulation of glucose homeostasis (GLUT2, SGLT1, T1R3, ghrelin and its receptor) in the trachea of an animal model of obesity (Zucker rats). We found that the tracheal epithelium of obese animals was characterized by the presence of poorly differentiated cells. Ciliated and secretory cells were the cell lineages with greatest loss of differentiation. Severe epithelial alterations were associated with marked deposit of extracellular matrix in the lamina propria. The expression pattern of GLUT2 and SGLT1 glucose transporters was similar in the trachea of both the Zucker rat genotypes, whereas that of T1R3 was reduced in ciliated cells of obese rats. A different immunolocalization for ghrelin was also found in the trachea of obese rats. In conclusion, the tracheal morphological alterations in obese animals seem to compromise the expression of molecules involved in the homeostasis of glucose.


Subject(s)
Gene Expression Regulation , Glucose/metabolism , Homeostasis , Obesity/metabolism , Trachea/metabolism , Animals , Glucose Transporter Type 2/biosynthesis , Obesity/pathology , Rats , Rats, Zucker , Receptors, G-Protein-Coupled/biosynthesis , Sodium-Glucose Transporter 1/biosynthesis , Trachea/pathology
6.
J Phys Condens Matter ; 28(22): 224005, 2016 06 08.
Article in English | MEDLINE | ID: mdl-26952789

ABSTRACT

The question of optical bandgap anisotropy in the monoclinic semiconductor ß-Ga2O3 was revisited by combining accurate optical absorption measurements with theoretical analysis, performed using different advanced computation methods. As expected, the bandgap edge of bulk ß-Ga2O3 was found to be a function of light polarization and crystal orientation, with the lowest onset occurring at polarization in the ac crystal plane around 4.5-4.6 eV; polarization along b unambiguously shifts the onset up by 0.2 eV. The theoretical analysis clearly indicates that the shift in the b onset is due to a suppression of the transition matrix elements of the three top valence bands at Γ point.

7.
Anat Histol Embryol ; 43(3): 239-44, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23822094

ABSTRACT

The morphology and the functionality of the murid glandular complex, composed of the submandibular and sublingual salivary glands (SSC), were the object of several studies conducted mainly using magnetic resonance imaging (MRI). Using a 4.7 T scanner and a manganese-based contrast agent, we improved the signal-to-noise ratio of the SSC relating to the surrounding anatomical structures allowing to obtain high-contrast 3D images of the SSC. In the last few years, the large development in resin melting techniques opened the way for printing 3D objects starting from a 3D stack of images. Here, we demonstrate the feasibility of the 3D printing technique of soft tissues such as the SSC in the rat with the aim to improve the visualization of the organs. This approach is useful to preserve the real in vivo morphology of the SCC in living animals avoiding the anatomical shape changes due to the lack of relationships with the surrounding organs in case of extraction. It is also harmless, repeatable and can be applied to explore volumetric changes occurring during body growth, excretory duct obstruction, tumorigenesis and regeneration processes. 3D printing allows to obtain a solid object with the same shape of the organ of interest, which can be observed, freely rotated and manipulated. To increase the visibility of the details, it is possible to print the organs with a selected zoom factor, useful as in case of tiny organs in small mammalia. An immediate application of this technique is represented by educational classes.


Subject(s)
Printing, Three-Dimensional , Rats/anatomy & histology , Sublingual Gland/anatomy & histology , Submandibular Gland/anatomy & histology , Animals
8.
Eur J Histochem ; 57(3): e24, 2013 Aug 06.
Article in English | MEDLINE | ID: mdl-24085273

ABSTRACT

The 3T3-L1 cell line, derived from 3T3 cells, is widely used in biological research on adipose tissue. 3T3-L1 cells have a fibroblast-like morphology, but, under appropriate conditions, they differentiate into an adipocyte-like phenotype. During the differentiation process, 3T3-L1 cells increase the synthesis of triglycerides and acquire the behavior of adipose cells. In particular, triglycerides accumulate in lipid droplets (LDs) embedded in the cytoplasm. The number and the size distribution of the LDs is often correlated with obesity and many other pathologies linked with fat accumulation. The integrated optical density (IOD) of the LDs is related with the amount of triglycerides in the droplets. The aim of this study is the attempt to characterize the size distribution and the IOD of the LDs in 3T3-L1 differentiated cells. The cells were differentiated into adipocytes for 5 days with a standard procedure, stained with Oil Red O and observed with an optical microscope. The diameter, area, optical density of the LDs were measured. We found an asymmetry of the kernel density distribution of the maximum Feret's diameter of the LDs with a tail due to very large LDs. More information regarding the birth of the LDs could help in finding the best mathematical model in order to analyze fat accumulation in adipocytes.


Subject(s)
Adipocytes/chemistry , Fibroblasts/chemistry , Lipids/chemistry , 3T3-L1 Cells , Adipocytes/cytology , Animals , Azo Compounds/chemistry , Cell Differentiation , Coloring Agents/chemistry , Mice , Optical Phenomena , Particle Size
9.
Monaldi Arch Chest Dis ; 77(2): 67-75, 2012 Jun.
Article in English | MEDLINE | ID: mdl-23193843

ABSTRACT

BACKGROUND: Pulmonary Rehabilitation ("Rehabilitation") can improve both lung function and quality of life in patients suffering from chronic obstructive pulmonary disease (COPD) even if only a very small proportion of patients have access to Rehabilitation. Supplementation of Essential Amino Acids (EAAs) might allow COPD patients to achieve some typical Rehabilitation outcomes such as a better physical performance and an improved health status. METHODS: 88 COPD out-patients (GOLD class 3-4) with a body mass index (BMI) < 23 Kg/m2 were randomised to receive EAAs (n = 44) or placebo (n = 44) for twelve weeks. Primary outcome measures were changes in both physical activities in daily life (measured by Sense Wear Armband in terms of mean steps walked in one week) and in quality of life (measured by the St George's Respiratory Questionnaire, SGRQ). RESULTS: After 12 weeks, the physical performance was significantly increased vs baseline only in patients who received EAAs (1140.33 +/- 524.69 and 638.68 +/- 662.1 steps/day, respectively; p = 0.02), being also the comparison vs the placebo group highly significant (p = 0.003). Similarly, the SGRQ score improved significantly only in EAA patients (69.35 +/- 9.51 vs baseline 72.04 +/- 8.62; p < 0.01), and changes were significantly different from those measured in the placebo group (p < 0.001). Furthermore, when compared to those who received placebo, EAAs patients significantly increased their fat-free mass (p = 0.04), muscle strength (p < 0.01), saturation of oxygen (p = 0.05), serum albumin (p < 0.001), and also ameliorated their original cognitive dysfunction (p = 0.02). CONCLUSIONS: Oral supplementation with EAAs contribute to improve the daily-life performance in domiciliary severe COPD patients who can not enter any Rehabilitation programme, together with their quality of life; nutritional and cognitive status, and muscle strength.


Subject(s)
Amino Acids, Essential/administration & dosage , Dietary Supplements , Exercise Tolerance/physiology , Outpatients , Pulmonary Disease, Chronic Obstructive/rehabilitation , Adult , Aged , Body Composition , Double-Blind Method , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/physiopathology , Quality of Life , Surveys and Questionnaires
10.
Q J Nucl Med Mol Imaging ; 56(3): 280-90, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22695338

ABSTRACT

In this review there will be presented an overview of the literature about the recent developments on radiotracers imaging using optical methods and their applications. We will begin with a short summary regarding the discovery of Cerenkov radiation (CR) and then focus on the early developments and experimental validation of planar Cerenkov luminescence imaging. A significant improvement in Cerenkov luminescence imaging was given by the development of tomographic methods in order to obtain in vivo whole body 3D images of Cerenkov sources. An interesting and original application discussed in this review is the use of CR as the excitation source of quantum dots and fluorophores. We will also present some recent experimental results on in vivo radio luminescence imaging of alpha and gamma emitters. All these results make optical radioisotopes imaging an interesting cost-effective tool for the screening of new probes for both imaging and therapeutic applications. Other interesting aspects are the uses of Cerenkov radiation for radiotherapy and for radiopharmaceuticals synthesis applications. We will conclude by summarising the most important results and the future challenges.


Subject(s)
Molecular Imaging/methods , Optical Phenomena , Radioisotopes , Animals , Humans , Luminescent Measurements , Radioisotopes/therapeutic use
11.
Eur J Histochem ; 55(2): e18, 2011 Jun 16.
Article in English | MEDLINE | ID: mdl-22193298

ABSTRACT

Essential oils are currently of great importance to pharmaceutical companies, cosmetics producers and manufacturers of veterinary products. They are found in perfumes, creams, bath products, and household cleaning substances, and are used for flavouring food and drinks. It is well known that some of them act on the respiratory apparatus. The increasing interest in optical imaging techniques and the development of related technologies have made possible the investigation of the optical properties of several compounds. Luminescent properties of essential oils have not been extensively investigated. We evaluated the luminescent and fluorescent emissions of several essential oils, in order to detect them in living organisms by exploiting their optical properties. Some fluorescent emission data were high enough to be detected in dermal treatments. Consequently, we demonstrated how the fluorescent signal can be monitored for at least three hours on the skin of living mice treated with wild chamomile oil. The results encourage development of this technique to investigate the properties of drugs and cosmetics containing essential oils.


Subject(s)
Chamomile/chemistry , Oils, Volatile , Plant Oils , Animals , Cosmetics/analysis , Cosmetics/chemistry , Cosmetics/pharmacology , Diagnostic Imaging/methods , Fluorescence , Mice , Oils, Volatile/analysis , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Plant Oils/analysis , Plant Oils/chemistry , Plant Oils/pharmacology
12.
Biomed Pharmacother ; 65(6): 401-6, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21719244

ABSTRACT

OBJECT: The work is aimed to develop a murine model of rectal cancer, which could be used to monitor lymph node metastasis development by magnetic resonance imaging (MRI) and optical imaging (OI) techniques. SUBJECTS AND METHODS: Ht-29 cancer cells were directly injected into the submucosal layer of the rectum of athymic nude mice using trans-anal rectal cancer cell injection (TARCI). Thirty-six mice were inoculated with 10×10(5) cells and five mice were treated with sterile phosphate buffer solution. One to 4 weeks after cell injection, tumor growth was evaluated in vivo using T2-weighted MRI at 4.7T. A further group of animal (n=6) treated with ht-29_luc cells, with the same protocol, was monitored by optical imaging. In both groups, the presence of the primary tumor and of lymph nodes metastasis was confirmed by histology. RESULTS: In all animals, primary tumors were detectable by MRI, 1 week from TARCI. After 4 weeks primary tumors showed a mean longitudinal diameter of about 2cm. All animals developed regional lymph node metastases. Others organs (e.g. lung or liver) were not affected. In fat-suppressed, T2-weighted MRI, lymph nodes appeared as small areas characterized by hyper-intense signal compared to muscle. OI permitted evaluation of the primary tumor growth in perineal region. CONCLUSIONS: TARCI of ht-29 cells into the rectum of nude mice is a feasible way to obtain a easily reproducible model of regional lymph node metastases could be monitored by magnetic resonance and optical imaging techniques.


Subject(s)
Disease Models, Animal , Early Detection of Cancer/methods , Lymphatic Metastasis/diagnosis , Molecular Imaging , Rectal Neoplasms/diagnosis , Animals , HT29 Cells , Humans , Luciferases/biosynthesis , Luciferases/genetics , Luminescent Agents , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphatic Metastasis/pathology , Magnetic Resonance Imaging , Male , Mice , Mice, Nude , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Transplantation/methods , Pilot Projects , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Rectal Neoplasms/genetics , Rectal Neoplasms/metabolism , Rectal Neoplasms/pathology , Rectum/metabolism , Rectum/pathology , Reproducibility of Results , Tumor Burden
13.
Monaldi Arch Chest Dis ; 73(1): 25-33, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20499791

ABSTRACT

AIM: Aim of the study was to investigate whether or not oral supplementation of essential amino acids (EAAs) may improve body composition, muscle metabolism, physical activity, cognitive function, and health status in a population of subjects with severe chronic obstructive pulmonary disease (COPD) and sarcopenia. METHODS: Thirty-two patients (25 males) (FEV1/FVC < 40% predicted), age 75 +/- 7 years, were randomised (n = 16 in both groups) to receive 4 gr/bid EAAs or placebo according to a double-blind design. When entered the study (T0), after four (T4), and after twelve (T12) weeks of treatments, body weight, fat free-mass (FFM), plasma lactate concentration (micromol/l), arterial PaCO2 and PaO2, physical activity (n degree steps/day), cognitive function (Mini Mental State Examination; MMSE), health status (St. George's Respiratory Questionnaire; SGRQ) were measured. RESULTS: EAAs supplemented, but not patients assuming placebo, progressively improved all baseline variables overtime. In particular, at T12 of EAAs supplementation, body weight (BW) increased by 6 Kg (p = 0.002), FFM by 3.6 Kg (p = 0.05), plasma lactate decreased from 1.6 micromol/l to 1.3 micromol/l (p = 0.023), PaO2 increased by 4.6 mmHg (p = 0.01), physical activity increased by 80% (p = 0.01). Moreover, the score for cognitive dysfunction improved from 19.1 scores to 20.8 (p = 0.011), while the SRGQ score also improved from 723 to 69.6 even though this trend did not reach the statistical significance. CONCLUSIONS. A three-month EAAs supplementation may have comprehensive effects on nutritional status; muscle energy metabolism; blood oxygen tension, physical autonomy; cognitive function, and perception of health status in patients with severe COPD and secondary sarcopenia.


Subject(s)
Amino Acids, Essential/therapeutic use , Dietary Supplements , Pulmonary Disease, Chronic Obstructive/complications , Sarcopenia/drug therapy , Sarcopenia/etiology , Aged , Aged, 80 and over , Female , Humans , Male , Quality of Life , Respiratory Function Tests , Sarcopenia/physiopathology , Weight Gain
14.
Magn Reson Med ; 62(4): 1080-4, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19725135

ABSTRACT

In activation-induced manganese-enhanced MRI (AIM-MRI) experiments, differential accumulation of Mn in activated and silent brain areas is generally assessed using T(1)-weighted images and quantified by the enhancement of signal intensity (SI), calculated with reference to SI before Mn administration or to SI of brain regions unaffected by the specific stimulus. However, SI enhancement can be unreliable when animals are removed from and reinserted into the magnet. We have developed an experimental protocol based on repeated intraperitoneal (i.p.) injections of Mn, quantitative determination of T(1), and coregistration of images to a rat brain atlas that allows absolute quantification of Mn concentration in selected brain areas. Results showed that interanimal variability of postcontrast T(1) values was very low (compared to the experimental error in T(1) determinations) allowing detection of differential regional Mn uptake in stimulated and unstimulated animals. In addition we have determined in vivo relaxivity of Mn in brain tissue and its frequency dependence.


Subject(s)
Brain Mapping/methods , Brain/anatomy & histology , Brain/physiology , Chlorides/pharmacokinetics , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Manganese Compounds/pharmacokinetics , Algorithms , Animals , Computer Simulation , Contrast Media/pharmacokinetics , Image Enhancement/methods , Male , Models, Neurological , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sensitivity and Specificity
15.
Naunyn Schmiedebergs Arch Pharmacol ; 378(4): 421-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18545984

ABSTRACT

Proton pump inhibitors exert their preventive and healing effects on gastropathy induced by nonsteroidal anti-inflammatory drug (NSAIDs) by a dual action: the antisecretory and the antioxidant effect. The latter was investigated by using esomeprazole against indomethacin-induced gastric mucosa lesions in rats and assessed by a histomorphometric analysis. Treatment by intragastric gavage were 1% methocel as vehicle; esomeprazole 10, 30, or 60 micromol/kg; indomethacin 100 micromol/kg; and esomeprazole 10, 30, or 60 micromol/kg plus indomethacin 100 micromol/kg. The evaluation of glutathione (GSH) levels and respiratory chain complex activities [nicotinamide adenine dinucleotide, reduced (NADH)-ubiquinone oxidoreductase, succinate dehydrogenase, cytochrome C reductase, cytochrome oxidase] was performed in the isolated gastric mucosa. Esomeprazole (10-60 micromol/kg) dose dependently reversed, up to complete recovery, the inhibitory effect of indomethacin on GSH levels (approximately 60% inhibition) and mitochondrial enzyme activities (inhibition ranging from 60% to 75%). Indomethacin-induced mucosal injuries were reduced by esomeprazole. Thus, in addition to inhibiting acid secretion, the gastroprotective effect of esomeprazole can be ascribed to a reduction in gastric oxidative injury.


Subject(s)
Esomeprazole/pharmacology , Gastric Mucosa/drug effects , Glutathione/metabolism , Indomethacin/toxicity , Mitochondria/drug effects , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Anti-Ulcer Agents/administration & dosage , Anti-Ulcer Agents/pharmacology , Dose-Response Relationship, Drug , Electron Transport Complex I/metabolism , Electron Transport Complex II/metabolism , Esomeprazole/administration & dosage , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Glutathione Disulfide/metabolism , Indomethacin/administration & dosage , Intubation, Gastrointestinal , Male , Membrane Transport Proteins/metabolism , Mitochondria/metabolism , Necrosis , Oxidative Phosphorylation/drug effects , Rats , Rats, Wistar , Spectrophotometry/methods , Stomach Diseases/chemically induced , Stomach Diseases/metabolism , Stomach Diseases/pathology
16.
Oncogene ; 27(18): 2542-51, 2008 Apr 17.
Article in English | MEDLINE | ID: mdl-17998939

ABSTRACT

Tumor microenvironment in carcinomas recruits mesenchymal cells with an abnormal proangiogenic and invasive phenotype. It is not clear whether mesenchymal tumor cells (MTCs) derive from the activation of mature fibroblasts or from their stem cell precursors. However, stromal cell activation in tumors resembles in several aspects the mesenchymal rearrangement which normally occurs during reparative processes such as wound healing. Mesenchymal stem cells (MSCs) play a crucial role in developmental and reparative processes and have extraordinary proangiogenic potential, on the basis of which they are thought to show great promise for the treatment of ischemic disorders. Here, we show that MTCs have proangiogenic potential and that they share the transcriptional expression of the best-known proangiogenic factors with MSCs. We also found that MTCs and MSCs have the same molecular signature for stemness-related genes, and that when co-implanted with cancer cells in syngeneic animals MSCs determine early tumor appearance, probably by favoring the angiogenic switch. Our data (1) reveal crucial aspects of the proangiogenic phenotype of MTCs, (2) strongly suggest their stem origin and (3) signal the risk of therapeutic use of MSCs in tumor-promoting conditions.


Subject(s)
Angiogenic Proteins/biosynthesis , Gene Expression Regulation, Neoplastic , Mammary Neoplasms, Animal/metabolism , Mesenchymal Stem Cell Transplantation/adverse effects , Mesenchymal Stem Cells/metabolism , Neovascularization, Pathologic/metabolism , Animals , Cell Line, Tumor , Fibroblasts/metabolism , Fibroblasts/pathology , Ischemia/metabolism , Ischemia/pathology , Ischemia/therapy , Mammary Neoplasms, Animal/pathology , Mesenchymal Stem Cells/pathology , Mice , Neoplasm Transplantation , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Neovascularization, Pathologic/pathology , Rats , Stromal Cells/metabolism , Stromal Cells/pathology , Transcription, Genetic , Transplantation, Isogeneic
17.
Radiol Med ; 112(3): 319-28, 2007 Apr.
Article in English, Italian | MEDLINE | ID: mdl-17440699

ABSTRACT

PURPOSE: The purpose of this study was to evaluate the applications of magnetic resonance imaging (MRI), and in particular, dynamic contrast-enhanced MRI (DCE-MRI), in the assessment of tumour microvasculature by means of animal tumour models evaluated before and after antiangiogenic treatment. MATERIALS AND METHODS: Forty-two MRI exams were performed with intravascular contrast media in 21 rats: tumours were induced by subcutaneous injection of colon carcinoma cells in 7 rats and mammary adenocarcinoma cells in 14 rats. Perfusion and permeability parameters of the implanted tumours were evaluated by using two contrast media (B22956/1 and Gd-DTPA37-albumin) to establish response to treatment with two different antiangiogenic drugs (tamoxifen and SU6668). These parameters were correlated with histology to obtain a radiological-histological map of tumour microvasculature. RESULTS: DCE-MRI revealed greater enhancement in the peripheral area than in the central area in all the examined animal models. In the mammary carcinoma experiment, vascular permeability measured by means of B22956/1 in the animals treated with the antiangiogenic drug (0.0043317+/-0.0040418 ml/min(-1)/ml(-1)) was significantly less than in untreated animals (0.0090460+/-0.0043680 ml/min(-1)/ml(-1)), whereas no significant difference was observed with Gd-DTPA-albumin (13.14+/-13.94 ml/min(-1)/ml(-1) in treated animals and 18.07+/-11.92 ml/min(-1)/ml(-1) in untreated animals). In the colon carcinoma experiment, mean permeability and perfusion decreased by 51% (from 5.2+/-1.1 to 2.5+/-0.8 ml/100 ml) and 59% (from 0.00165+/-5.1 to 0.0067+/-4.8 ml/min(-1)/ml(-1) of tissue), respectively, in all animals after antiangiogenic drug administration. CONCLUSIONS: DCE-MRI permits a noninvasive evaluation of tumour microcirculation and in particular of its dynamic characteristics and vascularity before and after antiangiogenic treatment.


Subject(s)
Adenocarcinoma/blood supply , Adenocarcinoma/diagnosis , Colonic Neoplasms/blood supply , Colonic Neoplasms/diagnosis , Magnetic Resonance Imaging/methods , Mammary Neoplasms, Experimental/blood supply , Neoplasms, Experimental/blood supply , Neoplasms, Experimental/diagnosis , Adenocarcinoma/drug therapy , Albumins , Angiogenesis Inhibitors/therapeutic use , Animals , Antineoplastic Agents, Hormonal/therapeutic use , Colonic Neoplasms/drug therapy , Contrast Media , Gadolinium DTPA , Indoles/therapeutic use , Mammary Neoplasms, Experimental/diagnosis , Mammary Neoplasms, Experimental/drug therapy , Microcirculation , Neoplasms, Experimental/drug therapy , Organometallic Compounds , Oxindoles , Propionates , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrroles/therapeutic use , Rats , Tamoxifen/therapeutic use
18.
Spinal Cord ; 39(8): 437-41, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11512074

ABSTRACT

OBJECTIVE: To measure resting energy expenditure (REE) in a group of people with postacute paraplegia, quantify the impact of asymptomatic bacteriuria and pressure sore(s) on patients' metabolic rate, and estimate the adequacy of patients' nutritional intakes to preserve patients' protein levels. MATERIAL AND METHODS: Ten males with post-acute paraplegia aged 42.1+/-18.7 years. We evaluated: height, body mass index (BMI), resting energy expenditure (REE), total daily calorie requirement (E), 24-h urine creatinine excretion (Cru), creatinine index (CI), and nitrogen balance (NB). RESULTS: Subjects with paraplegia showed high erythrocyte sedimentation rates. As a group, they had normal resting calorie consumption when REE was normalized for unit of urine creatinine (REE/Cru), it was higher in patients than in controls. Six of the 10 patients had a low calorie intake: of these only three had a negative nitrogen balance. CONCLUSION: In conclusion, the resting energy expenditure of the subjects with significant bacteriuria and pressure sore(s) of 23.7 kcal/kg/day suggests that a large portion of patients may have an inadequate calorie protein intake to preserve their nutritional status. The clinical significance of this study is that 28.5 kcal/kg/day may be the lower calorie threshold to meet the metabolic demands of people with apyretic paraplegia with bacteriuria and pressure sore(s).


Subject(s)
Bacteriuria/metabolism , Energy Metabolism/physiology , Nutritional Status , Paraplegia/rehabilitation , Pressure Ulcer/metabolism , Adolescent , Adult , Aged , Bacteriuria/etiology , Blood Urea Nitrogen , Creatinine/blood , Creatinine/urine , Energy Intake , Female , Humans , Male , Middle Aged , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiology , Paraplegia/complications , Pressure Ulcer/etiology
19.
Yeast ; 18(7): 663-70, 2001 May.
Article in English | MEDLINE | ID: mdl-11329176

ABSTRACT

The absence of triose phosphate isomerase activity causes an accumulation of only one of the two trioses, dihydroxyacetone phosphate, and this produces a shift in the final product of glucose catabolism from ethanol to glycerol (Compagno et al., 1996). Alterations of glucose metabolism imposed by the deletion of the TPI1 gene in Saccharomyces cerevisiae were studied in batch and continuous cultures. The Deltatpi1 null mutant was unable to grow on glucose as the sole carbon source. The addition of ethanol or acetate in media containing glucose, but also raffinose or galactose, relieved this effect in batch cultivation, suggesting that the Crabtree effect is not the primary cause for the mutant's impaired growth on glucose. The addition of an energy source like formic acid restored glucose utilization, suggesting that a NADH/energy shortage in the Deltatpi1 mutant could be a cause of the impaired growth on glucose. The amount of glycerol production in the Deltatpi1 mutant could represent a good indicator of the fraction of carbon source channelled through glycolysis. Data obtained in continuous cultures on mixed substrates indicated that different contributions of glycolysis and gluconeogenesis, as well as of the HMP pathway, to glucose utilization by the Deltatpi1 mutant may occur in relation to the fraction of ethanol present in the media.


Subject(s)
Glucose/metabolism , Saccharomyces cerevisiae/enzymology , Triose-Phosphate Isomerase/metabolism , Bioreactors , Dihydroxyacetone/analysis , Dihydroxyacetone/biosynthesis , Gene Deletion , Glycerol/analysis , Mutagenesis , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Triose-Phosphate Isomerase/deficiency , Triose-Phosphate Isomerase/genetics
20.
Yeast ; 18(7): 671-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11329177

ABSTRACT

In order to keep subscribers up-to-date with the latest developments in their field, this current awareness service is provided by John Wiley & Sons and contains newly-published material on yeasts. Each bibliography is divided into 10 sections. 1 Books, Reviews & Symposia; 2 General; 3 Biochemistry; 4 Biotechnology; 5 Cell Biology; 6 Gene Expression; 7 Genetics; 8 Physiology; 9 Medical Mycology; 10 Recombinant DNA Technology. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted. (4 weeks journals - search completed 7th Mar. 2001)


Subject(s)
Yeasts , Yeasts/genetics , Yeasts/metabolism , Yeasts/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...